Vanda Pharmaceuticals Inc.
A biopharmaceutical company that develops and commercializes treatments for central nervous system disorders. It markets drugs to treat non-24-hour sleep-wake syndrome and schizophrenia, and is developing drugs to treat sleep disorders associated with autism spectrum disorder and Parkinson's disease. It is a Delaware-based company.
Overview
Overview | |
|---|---|
Country | United States |
State | District of Columbia |
Employees | 203 |
Founded | |
Financials | |
|---|---|
Market Capitalization | 344.53M |
Revenue | 177.60M |
Operating Income | -25.19M |
Operating Margin | -14.18% |
Net Income | -4.89M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4086 / 5373 |
Sector : Healthcare | 556 / 1144 |
Industry : Biotechnology | 220 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 3255 / 5565 |
Sector : Healthcare | 498 / 1182 |
Industry : Biotechnology | 241 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 3194 / 5436 |
Sector : Healthcare | 248 / 1164 |
Industry : Biotechnology | 65 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 3549 / 5330 |
Sector : Healthcare | 463 / 1174 |
Industry : Biotechnology | 140 / 667 |